Literature DB >> 25583515

Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation.

Ning Feng1, Sabine Huke2, Guangshuo Zhu1, Carlo G Tocchetti3, Sa Shi1, Takeshi Aiba4, Nina Kaludercic5, Donald B Hoover6, Sarah E Beck7, Joseph L Mankowski7, Gordon F Tomaselli1, Donald M Bers8, David A Kass1, Nazareno Paolocci9.   

Abstract

BDNF and its associated tropomyosin-related kinase receptor B (TrkB) nurture vessels and nerves serving the heart. However, the direct effect of BDNF/TrkB signaling on the myocardium is poorly understood. Here we report that cardiac-specific TrkB knockout mice (TrkB(-/-)) display impaired cardiac contraction and relaxation, showing that BDNF/TrkB signaling acts constitutively to sustain in vivo myocardial performance. BDNF enhances normal cardiomyocyte Ca(2+) cycling, contractility, and relaxation via Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). Conversely, failing myocytes, which have increased truncated TrkB lacking tyrosine kinase activity and chronically activated CaMKII, are insensitive to BDNF. Thus, BDNF/TrkB signaling represents a previously unidentified pathway by which the peripheral nervous system directly and tonically influences myocardial function in parallel with β-adrenergic control. Deficits in this system are likely additional contributors to acute and chronic cardiac dysfunction.

Entities:  

Keywords:  BDNF; CaMKII; TrkB receptor; cardiac contractility/relaxation; neurotrophins

Mesh:

Substances:

Year:  2015        PMID: 25583515      PMCID: PMC4330748          DOI: 10.1073/pnas.1417949112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 2.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 3.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  CaMKII regulation of phospholamban and SR Ca2+ load.

Authors:  Alicia Mattiazzi; Evangelia G Kranias
Journal:  Heart Rhythm       Date:  2010-11-23       Impact factor: 6.343

5.  Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway.

Authors:  Sho Okada; Masataka Yokoyama; Haruhiro Toko; Kaoru Tateno; Junji Moriya; Ippei Shimizu; Aika Nojima; Takashi Ito; Yohko Yoshida; Yoshio Kobayashi; Hideki Katagiri; Tohru Minamino; Issei Komuro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-03       Impact factor: 8.311

Review 6.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 7.  Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.

Authors:  Pouneh Kermani; Barbara Hempstead
Journal:  Trends Cardiovasc Med       Date:  2007-05       Impact factor: 6.677

Review 8.  Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals.

Authors:  Bente K Pedersen; Maria Pedersen; Karen S Krabbe; Helle Bruunsgaard; Vance B Matthews; Mark A Febbraio
Journal:  Exp Physiol       Date:  2009-09-11       Impact factor: 2.969

9.  Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes.

Authors:  Sabine Huke; Donald M Bers
Journal:  Biochem Biophys Res Commun       Date:  2008-08-26       Impact factor: 3.575

10.  Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity.

Authors:  O G Vidaurre; S Gascón; R Deogracias; M Sobrado; E Cuadrado; J Montaner; A Rodríguez-Peña; M Díaz-Guerra
Journal:  Cell Death Dis       Date:  2012-01-19       Impact factor: 8.469

View more
  37 in total

Review 1.  Cardiac sympathetic innervation, from a different point of (re)view.

Authors:  Tania Zaglia; Marco Mongillo
Journal:  J Physiol       Date:  2017-06-15       Impact factor: 5.182

2.  Involvement of neurotrophic signaling in doxorubicin-induced cardiotoxicity.

Authors:  Dehua Liao; Chen Zhang; Ni Liu; Lizhi Cao; Changshui Wang; Qingyan Feng; Dunwu Yao; Minghui Long; Pei Jiang
Journal:  Exp Ther Med       Date:  2019-12-04       Impact factor: 2.447

3.  Hold the salt: vasopressor role for BDNF.

Authors:  Krisztina Marosi; Mark P Mattson
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

Review 4.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

5.  Integrating Clinical Data and Imputed Transcriptome from GWAS to Uncover Complex Disease Subtypes: Applications in Psychiatry and Cardiology.

Authors:  Liangying Yin; Carlos K L Chau; Pak-Chung Sham; Hon-Cheong So
Journal:  Am J Hum Genet       Date:  2019-11-27       Impact factor: 11.025

Review 6.  Molecular Mechanisms of Sympathetic Remodeling and Arrhythmias.

Authors:  Ryan T Gardner; Crystal M Ripplinger; Rachel C Myles; Beth A Habecker
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-02

7.  Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.

Authors:  Brian D Piening; Wenyu Zhou; Kévin Contrepois; Hannes Röst; Gucci Jijuan Gu Urban; Tejaswini Mishra; Blake M Hanson; Eddy J Bautista; Shana Leopold; Christine Y Yeh; Daniel Spakowicz; Imon Banerjee; Cynthia Chen; Kimberly Kukurba; Dalia Perelman; Colleen Craig; Elizabeth Colbert; Denis Salins; Shannon Rego; Sunjae Lee; Cheng Zhang; Jessica Wheeler; M Reza Sailani; Liang Liang; Charles Abbott; Mark Gerstein; Adil Mardinoglu; Ulf Smith; Daniel L Rubin; Sharon Pitteri; Erica Sodergren; Tracey L McLaughlin; George M Weinstock; Michael P Snyder
Journal:  Cell Syst       Date:  2018-01-17       Impact factor: 10.304

8.  Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.

Authors:  Gizem Keceli; Ashish Gupta; Joevin Sourdon; Refaat Gabr; Michael Schär; Swati Dey; Carlo G Tocchetti; Annina Stuber; Jacopo Agrimi; Yi Zhang; Michelle Leppo; Charles Steenbergen; Shenghan Lai; Lisa R Yanek; Brian O'Rourke; Gary Gerstenblith; Paul A Bottomley; Yibin Wang; Nazareno Paolocci; Robert G Weiss
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

9.  Sirt1 improves heart failure through modulating the NF-κB p65/microRNA-155/BNDF signaling cascade.

Authors:  Bin Lin; Hui Zhao; Li Li; Zhenzhen Zhang; Nan Jiang; Xiaowei Yang; Tao Zhang; Bowen Lian; Yaokai Liu; Chi Zhang; Jiaxiang Wang; Feng Wang; Deguang Feng; Jing Xu
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

10.  R13 preserves motor performance in SOD1G93A mice by improving mitochondrial function.

Authors:  Xiao Li; Chongyang Chen; Xu Zhan; Binyao Li; Zaijun Zhang; Shupeng Li; Yongmei Xie; Xiangrong Song; Yuanyuan Shen; Jianjun Liu; Ping Liu; Gong-Ping Liu; Xifei Yang
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.